colistimethate sodium (TQD3524)
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 26, 2024
TQD3524-I-02: To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Infectious Disease • Renal Disease
1 to 1
Of
1
Go to page
1